Guggenheim raised the firm’s price target on Legence (LGN) to $68 from $53 and keeps a Buy rating on the shares ahead of Q4 results due later this week. Consensus 2026 expectations “continue to be too low,” the analyst tells investors in a preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN: